On Sept. 14, 2021, Emergent BioSolutions announced a five-year contract development and manufacturing (CDMO) services agreement spanning Emergentﾒs…
On Sept. 14, 2021, Twist Bioscience announced that it had started shipping its synthetic RNA reference controls for…
On Sept. 14, 2021, Regeneron announced an agreement with the U.S. Department of Health and Human Services and…
On Sept. 14, 2021, City of Hope announced that it had begun enrolling patients in a Phase 2…
On Sept. 13, 2021, Twist Bioscience announced and Adicet Bio announced a collaboration to accelerate the discovery of…
On Sept. 10, 2021, Zoo Atlanta reported that it had received presumptive positive test results indicating that members…
On Sept. 10, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Sept. 9, 2021, Humanigen announced the U.S. FDA had declined its request for emergency use authorization of…
On Sept. 9, 2021, the National Institutes of Health (NIH) announced that it was providing approximately $185 million…
On Sept. 9, 2021, T2 Biosystems announced that its T2SARS-CoV-2 Panel – a molecular diagnostic test that detected…
On Sept. 8, 2021, AIM ImmunoTech announced that is had submitted a Pre-Investigational New Drug application (Pre-IND) to…
On Sept. 8, 2021, National Resilience announced an agreement to manufacture mRNA for the Moderna COVID-19 vaccine. Under…
On Sept. 8, 2021, Bio-Techne and Carterra announced a clinical research collaboration studying COVID-19 variants. To assess immune…
On Sept. 8, 2021, Novavax announced enrollment of the first participants in a Phase 1/2 study to evaluate…
On Sept. 7, 2021, Takeda Pharmaceutical announced the Government of Japan’s Ministry of Health, Labour and Welfare purchase…
On Sept. 6, 2021, a genomic analysis of lung cancer in people with no history of smoking has…
On Sept. 6, 2021, Pfizer and BioNTech announced that they had submitted a variation to the European Medicines…
On Sept. 3, 2021, the Centers for Disease Control and Prevention (CDC) awarded more than $116 million in…
On Sept. 3, 2021, Moderna announced that it had submitted for a conditional marketing approval (CMA) with the…
On Sept. 2 , 2021, an Oxford University Study showed that the most recent common ancestor of these…
On Sept. 2, 2021, Thermo Fisher Scientific announced a $192.5 million contract award from the U.S. Department of…
On Sept. 1, 2021, the World Health Organization inaugurated the new WHO Hub for Pandemic and Epidemic Intelligence…
On Sept. 1, 2021, Rigel Pharma announced the publication of results from a Phase 2 clinical trial evaluating…
On Sept. 1, 2021, Quidel announced it will make Quidelﾒs non-prescription QuickVueﾮ At-Home OTC COVID-19 Test available to…
On Sept. 1, 2021, Moderna announced it had initiated its submission to the U.S. Food and Drug Administration…
On Aug. 31, 2021, RELIEF THERAPEUTICS reported that the parent company of its U.S. collaboration partner, NRx Pharmaceuticals…
On Aug. 31, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Aug. 31, 2021, SK bioscience and GlaxoSmithKline announced the initiation of a Phase 3 clinical study of…
On Aug. 31, 2021, Novartis announced a commercial agreement with the NHS in England as part of a…
On Aug. 30, 2021, OPKO announced completion of enrollment in its Phase 2 trial with RAYALDEEﾮ as a…